UNITED STATES 
                   SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C. 20549
                                __________

                                 FORM 8-K

                              CURRENT REPORT

  Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
 
     Date of Report (Date of earliest event reported): July 18, 2005


                       PETMED EXPRESS, INC.
        ----------------------------------------------------
       (Exact name of registrant as specified in its charter) 

                  Commission file number 000-28827
                                         ---------

            FLORIDA                           65-0680967
  ---------------------------                 ------------
 (State or other jurisdiction                (IRS Employer
of incorporation or organization)         Identification No.)




1441 S.W. 29th Avenue, Pompano Beach, Florida           33069
---------------------------------------------       --------------
  (Address of principal executive offices)            (Zip Code)

Registrant's telephone number, including area code: (954) 979-5995
                                                    --------------

                          Not Applicable
    -----------------------------------------------------------
   (Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K is intended to 
simultaneously satisfy the filing obligation of the registrant under 
any of the following provisions:

[   ] Written communications pursuant to Rule 425 under the Securities Act

[   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act

[   ] Pre-commencement communications pursuant to Rule 14d-2(b) under 
      the Exchange Act

[   ] Pre-commencement communications pursuant to Rule 13e-4(c) under 
      the Exchange Act





Item 7.01	  Regulation FD Disclosure

On July 18, 2005, PetMed Express, Inc. issued a press release 
stating that it will announce its June 30, 2005 quarter end financial 
results and host a conference call to review the results on Monday, 
July 25, 2005.  A copy of this press release is attached hereto as 
Exhibit 99.1 and is incorporated herein by reference.

The information furnished in this Item 9, intended to be 
furnished under Item 12, is instead furnished under Item 9 in 
accordance with SEC Release 33-8216.  This information shall not be 
deemed "filed" for purposes of Section 18 of the Securities Exchange 
Act of 1934, as amended (the "Exchange Act") nor shall such 
information be incorporated by reference in any filing under the 
Securities Act of 1933, as amended, or the Exchange Act, except as 
shall be expressly set forth by specific reference in such filing.

Item 9.01	Financial Statements and Exhibits
	
(c)	Exhibits

99.1	Press Release issued by PetMed Express, Inc. on July 18, 2005





                             SIGNATURES


	Pursuant to the requirements of the Securities Exchange Act of 
1934, the Registrant has duly caused this report to be signed on its 
behalf by the undersigned hereunto duly authorized.

					
PETMED EXPRESS, INC.
(The "Registrant")

Date: July 20, 2005

By:  /s/  Menderes Akdag
     --------------------------
     Menderes Akdag

     Chief Executive Officer 
     (principal executive officer)

By:  /s/  Bruce S. Rosenbloom
     ---------------------------
     Bruce S. Rosenbloom

     Chief Financial Officer
     (principal financial and accounting officer)





                          EXHIBIT INDEX

Exhibit No.            Description


99.1	Press Release issued by PetMed Express on July 18, 2005